Application no. and date | 99952903.5 (espacenet) (Federated) (European Patent Register), 19990903 | Patent/reg. no. and date | DK/EP 1107795, 20021127 | Publication date | 20010620 | Priority no. and date | US 99103 P, 19980904, US 101759 P, 19980925 | EP pub. no. and date |
EP 1107795 20010620 | Effective date | | Applicant/owner | THE REGENTS OF THE UNIVERSITY OF MICHIGAN, 3003 S. State Street
Wolverine Tower, Room 2071
Ann Arbor
Michigan 48109-1280, US | Applicant ref. no. | P200300190 | Inventor | BREWER, George, J.
The University of Michigan, Dept. of H. Gen.&Int. Med.
4708 Medical ScienceII
Ann Arbor, MI 48109, US, MERAJVER, Sofia, D.
The University of Michigan, Dept. of Inter. Medicine
5510 Medical Science II
Ann Arbor, MI 48109, US, OCKWIG, Nathan
The University of Michigan, Dept. of Chemistry
Ann Arbor, MI 48109, US, COUCOUVANIS, Dimitri
The University of Michigan, Dept. of Chemistry
Ann Arbor, MI 48109, US, BREWER, George, 3820 Gensley Rd.
Ann Arbor, MI 48103, US, MERAJVER, Sofia, D., 2755 Daleview Drive
Ann Arbor, MI 48105, US | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | Opponent | | IPC Class | A61K 33/24, A61P 29/00, A61P 35/00, A61K 47/48 | Title | Thiomolybdat associeret med mindst ét carbohydrat og dets anvendelse til forebyggelse eller behandling af sygdomme kendetegnet ved aberrerende vascularisation, såsom cancer, maculadegeneration af våd type, rheumatoid arthritis | Int. application no. | PCT/US99/20374 | Int. publication no. | WO00013712 | Related patent (certificate) | | Status | Bortfaldet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|